121 related articles for article (PubMed ID: 1614964)
1. Intestinal absorption of peptides and peptide analogues: implications of fasting pancreatic serine protease levels and pH on the extent of oral absorption in dogs and humans.
Sinko PJ
Pharm Res; 1992 Mar; 9(3):320-5. PubMed ID: 1614964
[TBL] [Abstract][Full Text] [Related]
2. Variable gastric emptying and discontinuities in drug absorption profiles: dependence of rates and extent of cimetidine absorption on motility phase and pH.
Langguth P; Lee KM; Spahn-Langguth H; Amidon GL
Biopharm Drug Dispos; 1994 Dec; 15(9):719-46. PubMed ID: 7888602
[TBL] [Abstract][Full Text] [Related]
3. Variability in cimetidine absorption and plasma double peaks following oral administration in the fasted state in humans: correlation with antral gastric motility.
Takamatsu N; Welage LS; Hayashi Y; Yamamoto R; Barnett JL; Shah VP; Lesko LJ; Ramachandran C; Amidon GL
Eur J Pharm Biopharm; 2002 Jan; 53(1):37-47. PubMed ID: 11777751
[TBL] [Abstract][Full Text] [Related]
4. Regional differences in intestinal spreading and pH recovery and the impact on salmon calcitonin absorption in dogs.
Lee YH; Perry BA; Sutyak JP; Stern W; Sinko PJ
Pharm Res; 2000 Mar; 17(3):284-90. PubMed ID: 10801216
[TBL] [Abstract][Full Text] [Related]
5. Comparison of gastrointestinal pH in dogs and humans: implications on the use of the beagle dog as a model for oral absorption in humans.
Lui CY; Amidon GL; Berardi RR; Fleisher D; Youngberg C; Dressman JB
J Pharm Sci; 1986 Mar; 75(3):271-4. PubMed ID: 3701609
[TBL] [Abstract][Full Text] [Related]
6. Impact of regional intestinal pH modulation on absorption of peptide drugs: oral absorption studies of salmon calcitonin in beagle dogs.
Lee YH; Perry BA; Labruno S; Lee HS; Stern W; Falzone LM; Sinko PJ
Pharm Res; 1999 Aug; 16(8):1233-9. PubMed ID: 10468025
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the GI transit conditions in Beagle dogs with a telemetric motility capsule.
Koziolek M; Grimm M; Bollmann T; Schäfer KJ; Blattner SM; Lotz R; Boeck G; Weitschies W
Eur J Pharm Biopharm; 2019 Mar; 136():221-230. PubMed ID: 30703546
[TBL] [Abstract][Full Text] [Related]
8. Low Buffer Capacity and Alternating Motility along the Human Gastrointestinal Tract: Implications for in Vivo Dissolution and Absorption of Ionizable Drugs.
Hens B; Tsume Y; Bermejo M; Paixao P; Koenigsknecht MJ; Baker JR; Hasler WL; Lionberger R; Fan J; Dickens J; Shedden K; Wen B; Wysocki J; Loebenberg R; Lee A; Frances A; Amidon G; Yu A; Benninghoff G; Salehi N; Talattof A; Sun D; Amidon GL
Mol Pharm; 2017 Dec; 14(12):4281-4294. PubMed ID: 28737409
[TBL] [Abstract][Full Text] [Related]
9. [Effect of casein derived peptides on D-xylose absorption and small intestinal motility in dogs].
Defilippi C; Salas K; Michea L; Lagos N
Rev Med Chil; 1998 May; 126(5):520-4. PubMed ID: 9731433
[TBL] [Abstract][Full Text] [Related]
10. Role of regional absorption and gastrointestinal motility on variability in oral absorption of a model drug.
Narang AS; Balakrishnan A; Morrison J; Li J; Wang J; Gu H; Taylor K; Santone K; Ehrmann J; Beyer S; Lu X; Ketner R; Pizzano J; Orcutt T; Shields E; Dulac H; Aborn S; Batchelder M; Lentz K
Eur J Pharm Biopharm; 2017 Aug; 117():333-345. PubMed ID: 28455207
[TBL] [Abstract][Full Text] [Related]
11. Gastric pH changes associated with duodenal motility in fasted dogs.
Bueno L; Fioramonti J; Ruckebusch Y
J Physiol; 1981 Jul; 316():319-25. PubMed ID: 7320869
[TBL] [Abstract][Full Text] [Related]
12. Effect of intraduodenal administration of ursodeoxycholic acid on interdigestive interaction between gallbladder motility, pancreatic secretion and endocrine activity.
Neubrand MW; Dominguez-Munoz JE; Reichel C; Kampmann S; Eschmann K; von Falkenhausen M; Bregulla M; Malfertheiner P; Sauerbruch T
Digestion; 2004; 69(3):149-57. PubMed ID: 15114045
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic polypeptide and intestinal motility in dogs.
Thor PJ; Konturek JW; Konturek SJ
Dig Dis Sci; 1987 May; 32(5):513-9. PubMed ID: 3568938
[TBL] [Abstract][Full Text] [Related]
14. Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: in vitro permeability and in vivo oral absorption of salmon calcitonin (sCT).
Sinko PJ; Lee YH; Makhey V; Leesman GD; Sutyak JP; Yu H; Perry B; Smith CL; Hu P; Wagner EJ; Falzone LM; McWhorter LT; Gilligan JP; Stern W
Pharm Res; 1999 Apr; 16(4):527-33. PubMed ID: 10227707
[TBL] [Abstract][Full Text] [Related]
15. [Effect of pH on the motility of isolated jejunal loops in dogs].
Dolisi C; Ozon C; Ardisson JL
Arch Int Physiol Biochim; 1979 Aug; 87(3):433-41. PubMed ID: 93433
[TBL] [Abstract][Full Text] [Related]
16. Dissolution media simulating the proximal canine gastrointestinal tract in the fasted state.
Arndt M; Chokshi H; Tang K; Parrott NJ; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2013 Aug; 84(3):633-41. PubMed ID: 23434923
[TBL] [Abstract][Full Text] [Related]
17. Rate of flow of digesta and electrical activity of the small intestine in dogs and sheep.
Bueno L; Fioramonti J; Ruckebusch Y
J Physiol; 1975 Jul; 249(1):69-85. PubMed ID: 125331
[TBL] [Abstract][Full Text] [Related]
18. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide and the interrelation between intestinal motility and pancreatic secretion in fasted and fed dogs.
Maczka M; Thor P; Bilski J; Konturek SJ
J Physiol Pharmacol; 1994 Jun; 45(2):285-98. PubMed ID: 7949237
[TBL] [Abstract][Full Text] [Related]
20. Oral absorption of peptides: influence of pH and inhibitors on the intestinal hydrolysis of leu-enkephalin and analogues.
Friedman DI; Amidon GL
Pharm Res; 1991 Jan; 8(1):93-6. PubMed ID: 2014216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
